Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alx Oncology Holdings Inc
(NQ:
ALXO
)
2.650
+0.070 (+2.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,420,604
Open
2.580
Bid (Size)
2.560 (3)
Ask (Size)
2.740 (1)
Prev. Close
2.580
Today's Range
2.560 - 2.790
52wk Range
2.420 - 17.82
Shares Outstanding
40,869,135
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q2 2024
August 09, 2024
ALXO stock results show that ALX Oncology Holdings beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 08, 2024
From
ALX Oncology
Via
GlobeNewswire
Performance
YTD
-81.79%
-81.79%
1 Month
-66.88%
-66.88%
3 Month
-82.36%
-82.36%
6 Month
-83.27%
-83.27%
1 Year
-45.47%
-45.47%
More News
Read More
ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
August 06, 2024
From
ALX Oncology
Via
GlobeNewswire
Crude Oil Moves Lower; Moderna Shares Plunge
August 01, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
August 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
August 01, 2024
Via
Benzinga
Immuno-Oncology Focused ALX Oncology Stock Falls On Updated Data From Mid-Stage Evorpacept Combo Study In Gastric Cancer Patients
August 01, 2024
Via
Benzinga
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
August 01, 2024
Via
Benzinga
ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer
July 31, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
July 31, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
June 02, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
May 29, 2024
From
ALX Oncology
Via
GlobeNewswire
ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Appoints Allison Dillon as Chief Business Officer
May 07, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer
April 30, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
April 24, 2024
From
ALX Oncology
Via
GlobeNewswire
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 17, 2024
Via
Benzinga
ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”)
April 09, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer
March 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 08, 2024
Via
Benzinga
ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q4 2023
March 07, 2024
Via
InvestorPlace
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 07, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual Meeting
March 05, 2024
From
ALX Oncology
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.